Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma

29 Oct 2015

Abstract excerpt

// Jung Ho Kim 1, * , Jeong Mo Bae 2, * , Young Seok Song 3 , Nam-Yun Cho 3 , Hye Seung Lee 4 , Gyeong Hoon Kang 2, 3 1 Department of Pathology, SMG-SNU Boramae Medical Center, Seoul, Korea 2 Department of Pathology, Seoul National University College of Medicine, Seoul, Korea 3 Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea 4 Department of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Screening and Detection
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26528695
DOI: 10.18632/oncotarget.5618

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinomaPMID 26528695Read ↗

Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression StatusSemantic proximity Read ↗

Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature reviewSemantic proximity Read ↗

EPCAM deletions, Lynch syndrome, and cancer risk.Semantic proximity Read ↗

Shedding light on the EpCAM: An overviewSemantic proximity Read ↗

The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors.Semantic proximity Read ↗

A EPCAM Pathogenic Variant in Familial Lynch Syndrome-Associated Colon Cancer: Insights into Genetic Basis and Tumor Microenvironment CharacteristicsSemantic proximity Read ↗

Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedsideSemantic proximity Read ↗

Revisiting the Roles of Pro-Metastatic EpCAM in CancerSemantic proximity Read ↗

Analysis of EPCAM Protein Expression in Diagnostics of Lynch SyndromeSemantic proximity Read ↗

EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patientsSemantic proximity Read ↗

The Emerging Role of EpCAM in Cancer and Stem Cell SignalingSemantic proximity Read ↗

EpCAM in carcinogenesis: the good, the bad or the uglySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.